AstraZeneca | Results Presentation Deck | 41 slides

AstraZeneca · 2023-04
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

41
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
front_matter
Open slide detailBeat · Attention
04
Includes a photo of the CEO and a scientific illustration of a virus/cell structure.front_matter
Open slide detailBeat · Attention
05
Includes a navigation bar at the top indicating this is the 'CEO Opening Remarks' section.analyze_data
Open slide detailBeat · Need
06
The slide uses a horizontal stacked bar chart format to visualize revenue composition.summarize
Open slide detailBeat · Need
07
The slide uses a progress-tracking visual to show specific drug candidates and their trial names/indications.summarize
Open slide detailBeat · Need
08
Includes a headshot of the CFO and a scientific illustration related to the company's field.transition
Open slide detailBeat · Need
09
The slide uses a standard financial reporting format for quarterly results.analyze_data
Open slide detailBeat · Need
10
The slide uses a standard P&L structure with CER (Constant Exchange Rate) change metrics.analyze_data
Open slide detailBeat · Satisfaction
11
Includes a waterfall chart for net debt and qualitative guidance for revenue and EPS.analyze_data
Open slide detailBeat · Satisfaction
12
The slide uses a horizontal process-like layout to show AI application across the value chain.summarize
Open slide detailBeat · SatisfactionLoop · Golden Circle
13
introduce_nominees
Open slide detailBeat · SatisfactionLoop · Golden Circle
14
The slide uses a navigation bar at the top to indicate the current section (Oncology).analyze_data
Open slide detailBeat · SatisfactionLoop · Golden Circle
15
The slide uses a matrix structure to map drug assets (Imfinzi, Tagrisso, Enhertu, etc.) against patient segments and clinical trial names.present_framework
Open slide detailBeat · Satisfaction
16
Includes Kaplan-Meier survival curves and bar charts for pCR rates.analyze_data
Open slide detailBeat · SatisfactionLoop · Quick Win Big Bet
17
Slide 17 of a presentation deck. Includes detailed technical footnotes.summarize
Open slide detailBeat · SatisfactionLoop · Quick Win Big Bet
18
introduce_nominees
Open slide detailBeat · Satisfaction
19
The slide uses a consistent color-coded legend for products within each business unit chart.analyze_data
Open slide detailBeat · Satisfaction
20
R&I = respiratory and immunology. The slide uses a combination of bar charts for individual product trends and a donut chart for total revenue context.analyze_data
Open slide detailBeat · Satisfaction
21
The slide uses a color-coded legend to indicate development status (launched, approved/launch prep, Phase III, Phase II, Phase I).analyze_data
Open slide detailBeat · Satisfaction
22
Slide 22 of a presentation deck.summarize
Open slide detailBeat · Satisfaction
23
The slide uses a before-after comparison to highlight the speed advantage of AI in identifying antibody leads.present_solution
Open slide detailBeat · SatisfactionLoop · Before After
24
The slide features a portrait of the CEO and a scientific illustration of molecular structures.introduce_nominees
Open slide detailBeat · Satisfaction
25
Includes a stacked bar chart showing revenue trends by product over 7 quarters.analyze_data
Open slide detailBeat · Satisfaction
26
Includes a stacked bar chart for Soliris registry data and a trial design schematic for gefurulimab.analyze_data
Open slide detailBeat · Satisfaction
27
Includes a biological pathway diagram and a table of drug assets.present_solution
Open slide detailBeat · Visualization
28
summarize
Open slide detailBeat · Visualization
29
The slide uses a two-column layout to contrast near-term R&D milestones with long-term corporate strategy.summarize
Open slide detailBeat · Visualization
30
Slide 30 of a presentation, likely AstraZeneca given the executives listed.other
32
The slide highlights 5 regulatory approvals and 1 positive CHMP opinion.summarize
33
Includes progress against specific 2025/2026 targets.summarize
34
The chart illustrates the impact of COVID-19 medicine revenue on total Emerging Markets performance over time.analyze_data
35
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
36
Slide contains two distinct charts: a stacked bar chart for product sales and a grouped bar chart for collaboration revenue.analyze_data
37
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
38
CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.analyze_data
39
Data presented as stacked bar charts with corresponding data tables below each chart.analyze_data
40
CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.analyze_data
41
Data reflects post-acquisition reporting for Alexion products.analyze_data